Timothy B. Durham

782 total citations
21 papers, 518 citations indexed

About

Timothy B. Durham is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Timothy B. Durham has authored 21 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Timothy B. Durham's work include Osteoarthritis Treatment and Mechanisms (4 papers), Asymmetric Synthesis and Catalysis (4 papers) and Chemical Synthesis and Analysis (3 papers). Timothy B. Durham is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (4 papers), Asymmetric Synthesis and Catalysis (4 papers) and Chemical Synthesis and Analysis (3 papers). Timothy B. Durham collaborates with scholars based in United States, Canada and France. Timothy B. Durham's co-authors include William Roush, María‐Jesús Blanco, Timothy A. Shepherd, Marvin J. Miller, Marvin J. Miller, Cyrus J. Bacchi, Mary C. O’Sullivan, Brad M. Savall, Noel A. Powell and Nicolas Blanchard and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Timothy B. Durham

21 papers receiving 508 citations

Peers

Timothy B. Durham
Thomas Pauly United States
Pingchen Fan United States
Hidetoshi Shindoh United States
Jessica E. Friedman United States
Scott Potter United States
David M. Ritchie United States
Sudhir Raghavan United States
Timothy B. Durham
Citations per year, relative to Timothy B. Durham Timothy B. Durham (= 1×) peers Hiroo Koyama

Countries citing papers authored by Timothy B. Durham

Since Specialization
Citations

This map shows the geographic impact of Timothy B. Durham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy B. Durham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy B. Durham more than expected).

Fields of papers citing papers by Timothy B. Durham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy B. Durham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy B. Durham. The network helps show where Timothy B. Durham may publish in the future.

Co-authorship network of co-authors of Timothy B. Durham

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy B. Durham. A scholar is included among the top collaborators of Timothy B. Durham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy B. Durham. Timothy B. Durham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thompson, Brian R., Bram Brouwers, Hui-Rong Qian, et al.. (2025). LY3522348, A New Ketohexokinase Inhibitor: A First-in-Human Study in Healthy Adults. Diabetes Therapy. 16(7). 1399–1415. 1 indexed citations
2.
He, Rongjun, Jifeng Wang, Zhihong Yu, et al.. (2022). Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors. Journal of Medicinal Chemistry. 65(20). 13892–13909. 5 indexed citations
3.
Prentice, Kacey J., Stacy G. Wendell, Ying Liu, et al.. (2017). CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis. EBioMedicine. 27. 200–213. 38 indexed citations
4.
Liu, Ying, Kacey J. Prentice, Kyle W. Sloop, et al.. (2017). Synthesis and Characterization of Urofuranoic Acids: In Vivo Metabolism of 2-(2-Carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic Acid (CMPF) and Effects on in Vitro Insulin Secretion. Journal of Medicinal Chemistry. 60(5). 1860–1875. 19 indexed citations
5.
Durham, Timothy B., Chin Liu, Daniel R. Mudra, et al.. (2017). A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose. Journal of Medicinal Chemistry. 60(13). 5933–5939. 12 indexed citations
6.
Bueno, Ana B., Javier Agejas, Howard B. Broughton, et al.. (2017). Optimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational Preferences. Journal of Medicinal Chemistry. 60(23). 9807–9820. 8 indexed citations
7.
Durham, Timothy B. & María‐Jesús Blanco. (2015). Target Engagement in Lead Generation. Bioorganic & Medicinal Chemistry Letters. 25(5). 998–1008. 66 indexed citations
9.
Durham, Timothy B., Valentine J. Klimkowski, Christopher J. Rito, et al.. (2014). Identification of Potent and Selective Hydantoin Inhibitors of Aggrecanase-1 and Aggrecanase-2 That Are Efficacious in Both Chemical and Surgical Models of Osteoarthritis. Journal of Medicinal Chemistry. 57(24). 10476–10485. 21 indexed citations
10.
Swearingen, Craig, M.G. Chambers, Chaohua Lin, et al.. (2010). A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs. Osteoarthritis and Cartilage. 18(9). 1159–1166. 21 indexed citations
11.
Swearingen, Craig, John W. Carpenter, Robert W. Siegel, et al.. (2010). Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine. Osteoarthritis and Cartilage. 18(9). 1150–1158. 33 indexed citations
12.
Durham, Timothy B. & Timothy A. Shepherd. (2006). Progress toward the discovery and development of efficacious BACE inhibitors.. PubMed. 9(6). 776–91. 49 indexed citations
13.
Durham, Timothy B., Nicolas Blanchard, Brad M. Savall, Noel A. Powell, & William Roush. (2004). Total Synthesis of Formamicin. Journal of the American Chemical Society. 126(30). 9307–9317. 40 indexed citations
14.
Durham, Timothy B. & William Roush. (2003). Stereoselective Synthesis of 2-Deoxy-β-Galactosides via 2-Deoxy-2-bromo- and 2-Deoxy-2-iodo-galactopyranosyl Donors. Organic Letters. 5(11). 1871–1874. 42 indexed citations
15.
Durham, Timothy B. & William Roush. (2003). Stereoselective Synthesis of Functionalized Precursors of the CDEF and CDE 2,6-Dideoxy-tetra- and Trisaccharide Units of Durhamycins A and B. Organic Letters. 5(11). 1875–1878. 22 indexed citations
16.
Durham, Timothy B. & Marvin J. Miller. (2002). An Enantioselective Synthesis of Differentially Protected erythro-α,β-Diamino Acids and Its Application to the Synthesis of an Analogue of Rhodopeptin B5. The Journal of Organic Chemistry. 68(1). 35–42. 22 indexed citations
17.
Durham, Timothy B. & Marvin J. Miller. (2002). Enantioselective Synthesis of α-Amino Acids fromN-Tosyloxy β-Lactams Derived from β-Keto Esters. The Journal of Organic Chemistry. 68(1). 27–34. 19 indexed citations
18.
Durham, Timothy B. & Marvin J. Miller. (2001). Conversion of Glucuronic Acid Glycosides to Novel Bicyclic β-Lactams. Organic Letters. 4(1). 135–138. 25 indexed citations
19.
Cao, Zhongcheng, Laurence D. Rosenhein, Lance McCoy, et al.. (1998). The Cellular Uptake Kinetics and Acute Biological Effects of Various Oxovanadium Species: A Comparative Study. Hormone and Metabolic Research. 30(1). 29–33. 2 indexed citations
20.
O’Sullivan, Mary C., Qibing Zhou, Zhili Li, et al.. (1997). Polyamine derivatives as inhibitors of trypanothione reductase and assessment of their trypanocidal activities. Bioorganic & Medicinal Chemistry. 5(12). 2145–2155. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026